- Home
- MAPS vs XFOR Comparison
MAPS vs XFOR Comparison
Compare MAPS & XFOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAPS
- XFOR
- Stock Information
- Founded
- MAPS 2008
- XFOR 2014
- Country
- MAPS United States
- XFOR United States
- Employees
- MAPS N/A
- XFOR N/A
- Industry
- MAPS Computer Software: Prepackaged Software
- XFOR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MAPS Technology
- XFOR Health Care
- Exchange
- MAPS Nasdaq
- XFOR Nasdaq
- Market Cap
- MAPS 131.9M
- XFOR 118.4M
- IPO Year
- MAPS N/A
- XFOR N/A
- Fundamental
- Price
- MAPS $1.12
- XFOR $3.37
- Analyst Decision
- MAPS Strong Buy
- XFOR Strong Buy
- Analyst Count
- MAPS 1
- XFOR 3
- Target Price
- MAPS $2.61
- XFOR $72.33
- AVG Volume (30 Days)
- MAPS 613.4K
- XFOR 145.5K
- Earning Date
- MAPS 05-08-2025
- XFOR 05-01-2025
- Dividend Yield
- MAPS N/A
- XFOR N/A
- EPS Growth
- MAPS N/A
- XFOR N/A
- EPS
- MAPS 0.08
- XFOR 2.16
- Revenue
- MAPS $184,737,000.00
- XFOR $31,364,000.00
- Revenue This Year
- MAPS $0.86
- XFOR $355.69
- Revenue Next Year
- MAPS $12.85
- XFOR $140.28
- P/E Ratio
- MAPS $13.66
- XFOR $1.55
- Revenue Growth
- MAPS N/A
- XFOR N/A
- 52 Week Low
- MAPS $0.70
- XFOR $3.05
- 52 Week High
- MAPS $1.65
- XFOR $34.20
- Technical
- Relative Strength Index (RSI)
- MAPS 45.59
- XFOR 22.18
- Support Level
- MAPS $1.11
- XFOR $3.05
- Resistance Level
- MAPS $1.21
- XFOR $3.41
- Average True Range (ATR)
- MAPS 0.07
- XFOR 0.62
- MACD
- MAPS 0.00
- XFOR -0.02
- Stochastic Oscillator
- MAPS 32.14
- XFOR 8.94
About MAPS WM Technology Inc.
WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on our marketplace ads.
About XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research and development of novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It has the ability to increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.